Lukas Baitsch, Ph.D.

Affiliations: 
Cancer Biology Dana-Farber Cancer Institute, Boston, MA, United States 
Google:
"Lukas Baitsch"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang Y, Li YM, Baitsch L, et al. (2018) Correction: MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells. Elife. 7
Yuzugullu H, Baitsch L, Von T, et al. (2015) A PI3K p110β-Rac signalling loop mediates Pten-loss-induced perturbation of haematopoiesis and leukaemogenesis. Nature Communications. 6: 8501
Li N, Fassl A, Chick J, et al. (2014) Cyclin C is a haploinsufficient tumour suppressor. Nature Cell Biology. 16: 1080-91
Wang Y, Lee YM, Baitsch L, et al. (2014) MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells. Elife. 3: e01763
Yuzugullu H, Baitsch L, Steiner A, et al. (2014) Abstract 4775: PI3K-p110β is required for leukemic transformation and HSC depletion in the absence of Pten Cancer Research. 74: 4775-4775
Hebeisen M, Baitsch L, Presotto D, et al. (2013) SHP-1 phosphatase activity counteracts increased T cell receptor affinity. The Journal of Clinical Investigation. 123: 1044-56
Gupta B, Iancu EM, Gannon PO, et al. (2012) Simultaneous coexpression of memory-related and effector-related genes by individual human CD8 T cells depends on antigen specificity and differentiation. Journal of Immunotherapy (Hagerstown, Md. : 1997). 35: 488-501
Baitsch L, Fuertes-Marraco SA, Legat A, et al. (2012) The three main stumbling blocks for anticancer T cells. Trends in Immunology. 33: 364-72
Baitsch L, Legat A, Barba L, et al. (2012) Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization. Plos One. 7: e30852
Baumgaertner P, Jandus C, Rivals JP, et al. (2012) Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells. International Journal of Cancer. Journal International Du Cancer. 130: 2607-17
See more...